Total Payments
$6,226
2024 Payments
$1,351
Companies
30
Transactions
341
Medicare Patients
5,042
Medicare Billing
$357,074
Payment Breakdown by Category
Food & Beverage$5,959 (95.7%)
Education$266.98 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,959 | 338 | 95.7% |
| Education | $266.98 | 3 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,598 | 113 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,141 | 66 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,001 | 26 | $0 (2024) |
| PFIZER INC. | $480.35 | 39 | $0 (2024) |
| Abbott Laboratories | $233.60 | 8 | $0 (2024) |
| CVRx, Inc. | $213.87 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $173.80 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $167.33 | 11 | $0 (2024) |
| Amgen Inc. | $156.21 | 6 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $135.04 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,351 | 82 | Novartis Pharmaceuticals Corporation ($342.46) |
| 2023 | $1,406 | 95 | Novartis Pharmaceuticals Corporation ($453.22) |
| 2022 | $907.34 | 59 | Novartis Pharmaceuticals Corporation ($374.88) |
| 2021 | $1,109 | 64 | Novartis Pharmaceuticals Corporation ($427.84) |
| 2020 | $207.93 | 13 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($115.68) |
| 2019 | $626.27 | 11 | AstraZeneca Pharmaceuticals LP ($524.60) |
| 2018 | $510.04 | 12 | AstraZeneca Pharmaceuticals LP ($351.64) |
| 2017 | $108.66 | 5 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($73.96) |
All Payment Transactions
341 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/12/2024 | Philips North America LLC | (9278) Bridge (Device) | Food and Beverage | Cash or cash equivalent | $63.10 | General |
| Category: Medical Device | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $20.72 | General |
| Category: Heart Failure and Hypertension | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $98.10 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/15/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $23.52 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/14/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $4.05 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $8.65 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/15/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/15/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/14/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,074 | 2,589 | $360,836 | $114,615 |
| 2022 | 16 | 1,466 | 1,801 | $338,307 | $110,909 |
| 2021 | 14 | 1,144 | 1,490 | $304,700 | $102,940 |
| 2020 | 10 | 358 | 412 | $80,659 | $28,610 |
Total Patients
5,042
Total Services
6,292
Medicare Billing
$357,074
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 207 | 373 | $55,706 | $24,443 | 43.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 112 | 122 | $47,635 | $15,828 | 33.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 185 | $36,940 | $13,769 | 37.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 248 | 258 | $48,109 | $13,015 | 27.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 105 | 175 | $26,978 | $10,282 | 38.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 40 | 41 | $35,446 | $8,769 | 24.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 79 | 80 | $17,795 | $4,281 | 24.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 51 | 62 | $14,905 | $3,741 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 40 | 40 | $10,960 | $3,639 | 33.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 507 | 601 | $13,823 | $3,418 | 24.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 390 | 451 | $10,373 | $2,504 | 24.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 27 | 27 | $8,181 | $2,162 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,992 | $1,975 | 24.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 31 | 31 | $7,902 | $1,843 | 23.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 18 | $3,846 | $1,533 | 39.9% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 15 | 17 | $5,381 | $1,373 | 25.5% |
| 93660 | Evaluation of heart function using tilt table | Facility | 2023 | 19 | 20 | $5,249 | $1,233 | 23.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 19 | 20 | $1,440 | $376.40 | 26.1% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 16 | 16 | $1,120 | $274.65 | 24.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $650.00 | $104.81 | 16.1% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 15 | 15 | $405.00 | $53.16 | 13.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 144 | 152 | $57,152 | $22,899 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 154 | 265 | $41,768 | $18,102 | 43.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 145 | $37,700 | $12,632 | 33.5% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 40 | 40 | $44,440 | $10,927 | 24.6% |
About Jerry White
Jerry White is a Cardiovascular Disease healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2014. The National Provider Identifier (NPI) number assigned to this provider is 1245655968.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jerry White has received a total of $6,226 in payments from pharmaceutical and medical device companies, with $1,351 received in 2024. These payments were reported across 341 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,959).
As a Medicare-enrolled provider, White has provided services to 5,042 Medicare beneficiaries, totaling 6,292 services with total Medicare billing of $357,074. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Ashland, KY
- Active Since 03/04/2014
- Last Updated 03/25/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1245655968
Products in Payments
- LifeVest (Device) $1,141
- ENTRESTO (Drug) $946.50
- LEQVIO (Drug) $651.90
- ELIQUIS (Drug) $496.23
- BRILINTA (Drug) $399.03
- Barostim Neo System (Device) $213.87
- JARDIANCE (Drug) $173.80
- Repatha (Biological) $156.21
- CardioMEMS HF System (Device) $136.83
- XARELTO (Drug) $135.04
- VYNDAQEL (Drug) $107.18
- VERQUVO (Drug) $96.63
- PRALUENT ALIROCUMAB INJECTION (Biological) $83.81
- FFRct (Device) $76.14
- HYPERLIPIDEMIA - DISEASE (Drug) $74.59
- CARDIOMEMS (Device) $71.74
- TYVASO (Drug) $71.33
- WATCHMAN Access System (Device) $65.41
- (9278) Bridge (Device) $63.10
- FARXIGA (Drug) $48.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Ashland
Sandeep Krishnan, Md, MD
Cardiovascular Disease — Payments: $152,109
Cardiovascular Disease $152,109
John Vanderen, Md, MD
Cardiovascular Disease — Payments: $20,913
Cardiovascular Disease $20,913
Aaron Hesselson, M.d, M.D
Cardiovascular Disease — Payments: $14,377
Cardiovascular Disease $14,377
Christopher Epling, Do, DO
Cardiovascular Disease — Payments: $10,369
Cardiovascular Disease $10,369
Dr. Charles Rhodes, M.d, M.D
Cardiovascular Disease — Payments: $8,842
Cardiovascular Disease $8,842
Jennifer Listerman, Md, MD
Cardiovascular Disease — Payments: $6,212
Cardiovascular Disease $6,212